Shrikala Baliga
Overview
Explore the profile of Shrikala Baliga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
202
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Biswal D, Shenoy M S, C B, Sureshkumar U, Acharya K V, Kamath M M, et al.
Indian J Med Microbiol
. 2025 Jan;
53():100792.
PMID: 39863107
Hydatid disease, caused by Echinococcus granulosus, remains a significant health concern in endemic regions. This case report aims to highlight the diagnostic challenges of pulmonary hydatid cysts in non-endemic areas,...
2.
Parthasarathy H, Modak A, Mahabala K, Natarajan S, Baliga S, Thomas M, et al.
BDJ Open
. 2024 Nov;
10(1):86.
PMID: 39582050
Context: Mineral Trioxide Aggregate (MTA) is a calcium silicate-based cement that potentially exhibits improved washout resistance when carboxymethyl chitosan or gelatin is incorporated. Gel-form MTA is a novel mineral trioxide...
3.
Remash A, Rao P, Shenoy S, Baliga S, Kassim S
F1000Res
. 2024 Jun;
13:36.
PMID: 38872735
Background: Tigecycline, a glycylcycline antibiotic is a promising option for the treatment of single or multidrug resistant pathogens. The aim of the study was to evaluate the in-vitro Tigecycline susceptibility...
4.
Veeraraghavan B, Bakthavatchalam Y, Manesh A, Lal B, Swaminathan S, Ansari A, et al.
Indian J Med Microbiol
. 2022 Dec;
41:71-80.
PMID: 36509611
Background: Levonadifloxacin (intravenous) and alalevonadifloxacin (oral prodrug) are novel antibiotics based on benzoquinolizine subclass of fluoroquinolone, licensed for clinical use in India in 2019. The active moiety, levonadifloxacin, is a...
5.
Acharya V, B U, Baliga S, Rai S
J Assoc Physicians India
. 2021 Sep;
69(8):11-12.
PMID: 34472822
No abstract available.
6.
Bhardwaj K, Shenoy M S, Baliga S, B U, Baliga B, Shetty V
Poult Sci
. 2021 May;
100(6):101094.
PMID: 33989952
The study was carried out to estimate the burden and pattern of antibiotic resistance and to identify antibiotic resistance genes with focus on ESBL producers, plasmid mediated quinolone resistance, and...
7.
Baliga B, Baliga S, Jain A, Kulal N, Kumar M, Koduvattat N, et al.
Malar J
. 2021 Mar;
20(1):139.
PMID: 33685454
Background: Malaria control system (MCS), an Information technology (IT)-driven surveillance and monitoring intervention is being adopted for elimination of malaria in Mangaluru city, Karnataka, India since October 2015. This has...
8.
Raj A, Baliga S, Shenoy M, Dhanashree B, Mithra P, Nambiar S, et al.
J Clin Tuberc Other Mycobact Dis
. 2020 Nov;
21:100198.
PMID: 33204853
•CB-NAAT performance compared in 831 suspected pulmonary and extrapulmonary suspected cases.•The conventional stained smear and CB-NAAT results were compared to the MGIT culture.•Sensitivity and specificity of CB-NAAT was 84.43% and...
9.
Baliga S, Mamtora D, Gupta V, Shanmugam P, Biswas S, Mukherjee D, et al.
Indian J Med Microbiol
. 2020 Nov;
38(3 & 4):307-312.
PMID: 33154240
Objectives: Levonadifloxacin is a novel benzoquinolizine subclass of quinolone with broad-spectrum activities against problematic pathogens such as methicillin-resistant Staphylococcus aureus, quinolone-resistant S. aureus, vancomycin intermediate S. aureus, and vancomycin-resistant S....
10.
Prabhu V, Coelho S, Achappa B, Baliga S, Sharon L, Shah J
J Clin Tuberc Other Mycobact Dis
. 2020 Sep;
21:100188.
PMID: 32995570
A 49-year-old male HIV positive patient on treatment failure presented with complaints of fever and dysphagia of three weeks duration and later on developed cervical lymphadenopathy along with severe vomiting...